Iowa Administrative Code › Agency 657 - Pharmacy Board › Chapter 37 - Iowa Prescription Monitoring Program › Rule 657-37.2 - Definitions

Current through Register Vol. 47, No. 3, July 24, 2024
For the purposes of this chapter, the following definitions
				shall apply.
"Administer"
means to provide or apply a
				controlled substance to a patient for immediate use within the prescribing
				practitioner's practice location. Administration does not include
				dispensing.
"Board"
means the Iowa board of
				pharmacy.
"Client"
means the owner, owner's designee, or
				other person responsible for an animal patient.
"Controlled substance"
means a drug in
				Schedules II through V set forth in Iowa Code chapter 124, division II.
"Council"
means the PMP advisory council
				established pursuant to Iowa Code section
				124.555 to provide oversight and
				to co-manage PMP activities with the board.
"CSA registration"
means registration with the
				board under the Iowa uniform controlled substances Act pursuant to 657-Chapter
				10.
"DEA number"
means the registration number
				issued to an individual or pharmacy by the U.S. Department of Justice, Drug
				Enforcement Administration (DEA), authorizing the individual or pharmacy to
				engage in the prescribing, dispensing, distributing, or procuring of a
				controlled substance.
"Dispense"
means to provide a controlled
				substance to a patient for self-use outside of the prescribing practitioner's
				practice location. Dispensing does not include administration.
"Dispenser"
means a pharmacy or prescriber,
				regardless of location, who delivers to the ultimate user a substance required
				to be reported to the PMP. "Dispenser" does not include a person exempt from
				reporting pursuant to subrule 37.7(2).
"First responder"
means an emergency medical
				care provider, a registered nurse staffing an authorized service program under
				Iowa Code section 147A.12, a physician assistant
				staffing an authorized service program under Iowa Code section
				147A.13, a firefighter, or a
				peace officer as defined in Iowa Code section
				801.4, who is trained and
				authorized to administer an opioid antagonist.
"Health care facility"
means a residential
				care facility, a nursing facility, an intermediate care facility for persons
				with mental illness, or an intermediate care facility for persons with an
				intellectual disability.
"Health care professional"
means a person who,
				by certification, registration, or licensure, is qualified to provide and is
				engaged in providing health care to patients. "Health care professional" does
				not include clerical or administrative staff. A health care professional shall
				be credentialed in a manner that permits verification and regulation of the
				health care professional's credentials.
"Health care system"
means an organization
				that includes at least one hospital or at least one group of practitioners that
				provides comprehensive care that are connected with each other through common
				ownership or management.
"HIPAA"
means the Health Insurance Portability
				and Accountability Act.
"Law enforcement"
means an entity or agency
				with jurisdiction to investigate or prosecute violations of criminal law. "Law
				enforcement" includes, but is not limited to, such agencies as police
				departments, United States attorneys, the DEA, county attorneys, and the
				Medicaid fraud control unit.
"Licensing authority"
means an agency that
				licenses or registers health care professionals and has jurisdiction to enforce
				governing laws over those individuals who are licensed or registered.
				"Licensing authority" includes, but is not limited to, professional licensing
				boards and the DEA.
"NarxCare"
means an analytics tool and care
				management platform that helps practitioners analyze real-time data from the
				PMP. The platform analyzes patient data and history to provide a patient risk
				score and usage patterns to help practitioners identify potential risk
				factors.
"NDC number"
means the universal product
				identifier used in the United States to identify a specific human drug.
"Opioid antagonist"
means a drug that binds to
				opioid receptors and blocks or inhibits the effects of opioids acting on those
				receptors with the intention to reverse overdose, including but not limited to
				naloxone hydrochloride or any other similarly acting drug approved by the
				United States Food and Drug Administration.
"Patient"
means a person or animal to whom a
				prescription is prescribed or dispensed.
"PMP administrator"
means staff persons
				designated to manage and administer the PMP under the direction and oversight
				of the board and the council.
"Practitioner"
means a prescriber or a
				pharmacist.
"Practitioner's delegate"
means a health care
				professional who is under the supervision of a PMP-registered practitioner and
				who is authorized by the practitioner to access PMP information on the
				practitioner's behalf.
"Prescriber"
means an individual with an
				active CSA registration who has the authority to prescribe controlled
				substances. For the purposes of this chapter, "prescriber" does not include a
				licensed veterinarian.
"Prescription monitoring program"
or
"PMP"
means the program established pursuant to these rules
				for the collection and maintenance of PMP information and for the provision of
				PMP information to authorized individuals.
"Reportable prescription"
means the record of
				a controlled substance administered or dispensed by a practitioner and the
				record of an opioid antagonist dispensed by a practitioner or administered by a
				first responder. "Reportable prescription" shall not include records identified
				in subrule 37.7(1). "Reportable prescription" shall include, but not be limited
				to:
1. The dispensing of a controlled
			 substance to an emergency department patient;
2. The administration of a controlled
			 substance to a patient at the discretion of the treating practitioner
3. The administration or dispensing of an
			 opioid antagonist to an emergency department patient;
4. The dispensing of a controlled substance
			 sample;
5. The dispensing of a
			 controlled substance or opioid antagonist to a patient upon discharge from a
			 hospital or care facility; and
6.
			 The dispensing of a Schedule V controlled substance without a prescription
			 pursuant to rule 657-10.33 (124,155A).